# Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200

> **NCT01585181** · PHASE1 · COMPLETED · sponsor: **Bavarian Nordic** · enrollment: 66 (actual)

## Conditions studied

- Cholera

## Interventions

- **BIOLOGICAL:** PXVX0200
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01585181
- **Lead sponsor:** Bavarian Nordic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-08
- **Final completion:** 2013-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2023-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01585181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01585181, "Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01585181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*